Breaking News Instant updates and real-time market news.

INFY

Infosys

$17.43

0.05 (0.29%)

18:12
04/23/18
04/23
18:12
04/23/18
18:12

Infosys sees FY18 revenue growth trending at 7.2% rate

Comments from the Infosys Analyst Day investor slides earlier today. In constant currency, revenue growth trending at 5.8% vs. 8.3% in FY17. Sees FY18 number of clients with over $100M deal value rising to 20 from 14 in FY16. Sees FY18 free cash flow at $1.95B vs. 1.69B in FY17. Sees FY18 Operating Margin 24.3% vs. 24.7% in FY17. Sees FY18 ROE rising to 23.9% from 22.0% in FY17.

  • 23

    Apr

INFY Infosys
$17.43

0.05 (0.29%)

04/13/18
BREN
04/13/18
NO CHANGE
Target $14
BREN
Sell
Infosys deteriorating profitability remains underappreciated, says Berenberg
After Infosys reported Q4 results that were in-line with consensus expectations and trimmed its FY19 EBIT margin guidance, Berenberg analyst Georgios Kertsos said he continues to think the market underappreciates that the company's growth is coming at the expense of profitability. The analyst, who believes the pricing pressure the company faces will persist, maintains a Sell rating on Infosys shares.
04/06/18
BREN
04/06/18
INITIATION
Target $14
BREN
Sell
Infosys initiated with a Sell at Berenberg
Berenberg analyst Georgio Kertsos initiated Infosys with a Sell and $14 price target citing deteriorating growth and margins due to historically low levels of investment. Kertsos expects pricing pressure to accelerate and for wage inflation to increasingly challenge profitability.
02/05/18
SUSQ
02/05/18
DOWNGRADE
SUSQ
Negative
Infosys downgraded to Negative from Neutral at Susquehanna
02/05/18
GSCO
02/05/18
UPGRADE
GSCO
Buy
Infosys upgraded to Buy from Neutral at Goldman Sachs

TODAY'S FREE FLY STORIES

DE

Deere

$156.59

1.52 (0.98%)

05:49
05/24/18
05/24
05:49
05/24/18
05:49
Upgrade
Deere rating change  »

UBS upgrades Deere to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKTR

Nektar

$82.81

0.87 (1.06%)

, BMY

Bristol-Myers

$52.49

0.14 (0.27%)

05:36
05/24/18
05/24
05:36
05/24/18
05:36
Recommendations
Nektar, Bristol-Myers, Merck analyst commentary  »

Nektar is…

NKTR

Nektar

$82.81

0.87 (1.06%)

BMY

Bristol-Myers

$52.49

0.14 (0.27%)

MRK

Merck

$59.16

0.7 (1.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 02

    Jun

  • 05

    Jun

  • 12

    Jun

  • 10

    Jul

  • 10

    Sep

  • 23

    Oct

ABBV

AbbVie

$105.60

-0.72 (-0.68%)

05:34
05/24/18
05/24
05:34
05/24/18
05:34
Downgrade
AbbVie rating change  »

AbbVie downgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 05

    Jun

GBNK

Guaranty Bancorp

$33.05

0.6 (1.85%)

, IBTX

Independent Bank

$74.20

-3.65 (-4.69%)

05:29
05/24/18
05/24
05:29
05/24/18
05:29
Downgrade
Guaranty Bancorp, Independent Bank rating change  »

Guaranty Bancorp…

GBNK

Guaranty Bancorp

$33.05

0.6 (1.85%)

IBTX

Independent Bank

$74.20

-3.65 (-4.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

EC

Ecopetrol

$21.15

-0.62 (-2.85%)

05:28
05/24/18
05/24
05:28
05/24/18
05:28
Upgrade
Ecopetrol rating change  »

Ecopetrol upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRML

Vermillion

$1.05

0.045 (4.48%)

05:27
05/24/18
05/24
05:27
05/24/18
05:27
Downgrade
Vermillion rating change  »

Vermillion downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CZR

Caesars

$12.50

-0.15 (-1.19%)

05:26
05/24/18
05/24
05:26
05/24/18
05:26
Initiation
Caesars initiated  »

Caesars initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLNT

Melinta Therapeutics

$6.25

-0.2 (-3.10%)

05:26
05/24/18
05/24
05:26
05/24/18
05:26
Syndicate
Melinta Therapeutics 22M share Secondary priced at $5.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

TDY

Teledyne

$198.96

2.19 (1.11%)

05:24
05/24/18
05/24
05:24
05/24/18
05:24
Hot Stocks
Teledyne awarded second phase of $47M contract from ESA »

The European Space…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOG

Northern Oil and Gas

$2.69

0.06 (2.28%)

05:22
05/24/18
05/24
05:22
05/24/18
05:22
Upgrade
Northern Oil and Gas rating change  »

Northern Oil and Gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDC

Rowan Companies

05:22
05/24/18
05/24
05:22
05/24/18
05:22
Upgrade
Rowan Companies rating change  »

Rowan Companies upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OI

Owens-Illinois

$18.85

-0.1 (-0.53%)

05:21
05/24/18
05/24
05:21
05/24/18
05:21
Upgrade
Owens-Illinois rating change  »

Owens-Illinois upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DE

Deere

$156.59

1.52 (0.98%)

05:21
05/24/18
05/24
05:21
05/24/18
05:21
Upgrade
Deere rating change  »

Deere upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNRC

Generac

$50.56

0.42 (0.84%)

05:21
05/24/18
05/24
05:21
05/24/18
05:21
Downgrade
Generac rating change  »

Generac downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

PBR

Petrobras

$15.10

-0.6 (-3.82%)

05:19
05/24/18
05/24
05:19
05/24/18
05:19
Downgrade
Petrobras rating change  »

Petrobras downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBR

Petrobras

$15.10

-0.6 (-3.82%)

05:19
05/24/18
05/24
05:19
05/24/18
05:19
Downgrade
Petrobras rating change  »

Petrobras downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$76.38

-0.465 (-0.61%)

05:19
05/24/18
05/24
05:19
05/24/18
05:19
Hot Stocks
Sandoz receives European Commission approval for Zessly »

Sandoz, a Novartis…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

ARCT

Arcturus Therapeutics

$6.66

-0.29 (-4.17%)

05:17
05/24/18
05/24
05:17
05/24/18
05:17
Hot Stocks
Arcturus Therapeutics comments on court ruling on former CEO 13D situation »

Arcturus Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

MTDR

Matador

$31.07

-0.735 (-2.31%)

05:14
05/24/18
05/24
05:14
05/24/18
05:14
Recommendations
Matador analyst commentary  »

Matador 'geared…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESYJY

easyJet

$0.00

(0.00%)

05:08
05/24/18
05/24
05:08
05/24/18
05:08
Downgrade
easyJet rating change  »

easyJet downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRMW

Primo Water

$15.48

0.56 (3.75%)

05:05
05/24/18
05/24
05:05
05/24/18
05:05
Initiation
Primo Water initiated  »

Primo Water initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALGN

Align Technology

$308.24

10.26 (3.44%)

05:04
05/24/18
05/24
05:04
05/24/18
05:04
Recommendations
Align Technology analyst commentary  »

Align Technology price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

CDNA

CareDx

$11.66

-0.12 (-1.02%)

04:55
05/24/18
05/24
04:55
05/24/18
04:55
Conference/Events
CareDx management to meet with Craig Hallum »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 29

    May

04:55
05/24/18
05/24
04:55
05/24/18
04:55
General news
Breaking General news story  »

Philadelphia Federal…

04:55
05/24/18
05/24
04:55
05/24/18
04:55
General news
Breaking General news story  »

3-Month Bill Announcement…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.